Edwards Lifesciences Corp
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| EDWARDS LIFESCIENCES CORPORATION | ||
| February 28, 2025 | By: | /s/ BERNARD J. ZOVIGHIAN |
|---|---|---|
| Bernard J. Zovighian Director andChief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ BERNARD J. ZOVIGHIAN | Director and Chief Executive Officer | February 28, 2025 |
| Bernard J. Zovighian | (Principal Executive Officer) | |
| /s/ SCOTT B. ULLEM | Corporate Vice President, Chief Financial Officer | February 28, 2025 |
| Scott B. Ullem | (Principal Financial Officer) | |
| /s/ ANDREW M. DAHL | Senior Vice President, Corporate Controller | February 28, 2025 |
| Andrew M. Dahl | (Principal Accounting Officer) | |
| /s/ LESLIE C. DAVIS | Director | February 28, 2025 |
| Leslie C. Davis | ||
| /s/ DAVID T. FEINBERG | Director | February 28, 2025 |
| David T. Feinberg | ||
| /s/ KIERAN T. GALLAHUE | Director | February 28, 2025 |
| Kieran T. Gallahue | ||
| /s/ LESLIE S. HEISZ | Director | February 28, 2025 |
| Leslie S. Heisz | ||
| /s/ PAUL A. LAVIOLETTE | Director | February 28, 2025 |
| Paul A. LaViolette | ||
| /s/ STEVEN R. LORANGER | Director | February 28, 2025 |
| Steven R. Loranger | ||
| /s/ RAMONA SEQUEIRA | Director | February 28, 2025 |
| Ramona Sequeira | ||
| /s/ NICHOLAS J. VALERIANI | Chairman of the Board | February 28, 2025 |
| Nicholas J. Valeriani | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.